Type 2 Diabetes Mellitus Clinical Trial
Official title:
Effectiveness of Shared Care Diabetes Management in Patients With Type 2 Diabetes
This is a prospective, randomization, parallel, controlled study to evaluate the
effectiveness of Shared Care diabetes management. Patients with T2DM involved in the Shared
Care model pay regularly quarterly visit to a multidisciplinary team led by physician at
outpatient clinic, and receive remote patient management and education after going home.
After at least 3 years follow-up, patients' metabolic indexes including HbA1c, LDL-c, blood
pressure, diabetes self-management behavior indexes and diabetes complications are evaluated.
The primary goal is to observe the HbA1c levels and the HbA1c achieving rate. The secondary
goal is to assess the diabetes self-management behavior change for patients of the Shared
Care multidisciplinary diabetes care model and to assess the effect of online diabetes
self-management support for patients of the Shared Care multidisciplinary diabetes care
model.
With population aging and increasing prevalence of obesity in China, the number of patients
with diabetes mellitus, healthcare expenditure and mortality related to DM are forecast to
grow substantially. 114 million diabetic patients and 11.6% incidence rate of diabetes yield
enormous chronic disease management pressure. China medical resources are not sufficient for
the great diabetes epidemic (1-5) . The data from a multicenter, cross-sectional survey of
outpatients conducted in 606 hospitals across China showed that the majority of patients with
type 2 diabetes did not achieve the goal of HbA1c <7.0% (6). We are facing problems including
inadequate patient education, unable to track the entire diabetic course, and the lack of
effective patient engagement in-between clinic visits(1-5). Diabetes management and education
can improve patients' quality of life, reduce incidence and mortality of diabetic
complications and relieve the medical economy burden for the government. (7).
International guidelines published by American Diabetes Association and the National
Institute and Health and Care Excellence in Hong Kong imply that a chronic disease service
delivery model that incorporates continuous follow-ups, DSMES (diabetes self-management
education and support) with a multidisciplinary team of health professionals to provide
ongoing treatments, patient education, and scheduled health assessments for monitoring of
disease control and complications has promoted internationally as a more holistic and
cost-effective way to manage patients with diabetes(8-12) . To help health professionals to
improve medical efficiency and help patients develop healthy lifestyle, we established Shared
Care diabetes management model and believe that it can provide a solution.
Shared Care Model aims to empower patients with diabetes self-management education and
supports (DSMES), achieve better health outcomes and delay incidence and mortality of
diabetic complications. Compared with traditional diabetes outpatient settings, patients of
Shared Care return to the hospital for regular follow-up every three months, and meet with a
multidisciplinary team includes diabetes educators, nurses, dietitians and physical therapist
led by the physician. The patients download the Shared Care mobile application during the
outpatient service and connect with the smart-glucometer Bg1 to upload blood glucose dairy in
real time. With patient's informed consent, his or her data from each visit will be collected
and recorded for analysis.
The internet, IOT (internet of Things) and other information technology enables the Shared
Care model to integrate outpatient and remote patient management, online and face-to-face
medical services and provide patients with comprehensive health care. Our health care
extended beyond the hospital. After the patient returns home from the clinic, they can
communicate through the APP with online diabetes educators. The educators answer patients'
questions, give suggestions on patients' diet and summarize patients' issues to physicians,
who provide high level supervision. The model enables both patients and medical team for
real-time data sharing, smart analysis and remote monitoring which significantly improve
management efficiency and release medical resources for more patients.
The Shared Care program in our hospital was established since Jan. 2018. Until Jul. 2019,
there are totally 1062 patients receiving continuous diabetes care which was provided by a
multidisciplinary team. 82.8% patients are followed regularly every three months, the HbA1c
achieving rate (<7%) is 69.5% after 1-year follow-up. Patient's self-management behavior
improves one year after admission. The study is aim to discover the influencing factors that
affect the HbA1c achieving rate and the efficiency and effect of the new model Shared Care.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02226003 -
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
|
Phase 3 |